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Background: Bacterial DNA is well-known for its potent immunostimulatory properties which have been attributed to
the abundance of CpG dinucleotides within the genomes of prokaryotes. Research has found that mammalian TLR9 is a
receptor which mediates the immune response to CpG DNA; however, its functional properties in non-mammalian
vertebrates are still poorly characterized. Leukocytes isolated from lower vertebrates, including teleosts, respond to
CpG DNA and TLR9 has been identified in many fish species; however, the ligand-binding properties of fish TLR9
have, so far, not been studied. The fact that some vertebrates, like chicken, lack TLR9 and use an alternative
molecule (TLR21) as a receptor for CpGs has questioned the functional conservation of TLR9 within vertebrates.
Results: In the current study, TLR9 from Atlantic salmon (SsTLR9) has been found to interact with synthetic
oligonucleotides via a CpG-independent but a pH-dependent mechanism. The endogenous receptor,
expressed by primary mononuclear phagocytes colocalizes with CpG oligonucleotides (ODNs) in vesicles that
appear to be endosomes. When overexpressed in salmonid cell lines, SsTLR9 spontaneously activates
ISRE-containing promoters of genes involved in the IFN response; however, the transgenic receptor fails to
translocate to CpG-containing endosomes. This indicates that only specific immune cell types have the ability
to relocate the receptor to the appropriate cellular compartments where it may become activated by its
ligand. In addition, through co-precipitation and mass spectrometry, two salmon proteins - hnRNPA0 and
NCOA5, which both contain RNA-binding domains (RRM), were found to bind CpG ODNs, suggesting they
may be involved in the CpG response in salmon leukocytes.
Conclusion: The presented data are the first to demonstrate that the DNA-binding properties of TLR9 are
conserved between teleosts and mammals. The current study also identifies additional molecules which may
function as mediators of the immunostimulatory properties of foreign DNA.
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Bacterial DNA is a potent immunostimulant [1] and
research has found that the abundance of CpG
dinucleotides (CpGs) in genomes of prokaryotes is a
major factor contributing to its immunostimulatory
properties [2]. Toll-like receptor 9 (TLR9) has been iden-
tified as a major player in the innate immune response to
bacterial DNA and synthetic oligodeoxynucleotides
(ODNs) that contain unmethylated CpG motifs [3].* Correspondence: jorunn.jorgensen@uit.no
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reproduction in any medium, provided the orThe members of the TLR family are well-conserved type
I transmembrane proteins characterized by a leucine-rich
domain involved in ligand recognition and a toll/interleu-
kin-1 receptor (TIR) intracellular signalling domain [4].
Acting as innate immune receptors, members of this family
have been found to mediate the response to different
bacteria- and virus-derived molecules, including lipopoly-
saccharide, bacterial lipopeptides [5], double-stranded
RNA [6] and CpGs [3].
Due to the importance of foreign- and host-derived
DNA for induction of protective reactions against
pathogens and autoimmune disorders, respectively, a
great deal of research has been devoted to studying the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of TLR9 (reviewed in [7]). In mammals, the receptor is
found in the endoplasmic reticulum in resting immune
cells. Upon exposure of the cells to CpG DNA, TLR9
translocates to the endosomal compartments [8], where
it may interact with its ligand. The binding of the recep-
tor to DNA seems to be sequence independent but it
requires low pH conditions and proteolytical activation
[9]. Once activated, the receptor signals through Myeloid
differentiation primary response gene 88 (MyD88) to
activate transcription factors including nuclear fac-
tor kappa-B (NFkB) and interferon-regulatory factor 7
(IRF7) involved in the upregulation of proinflammatory
genes and type I interferon (IFN), respectively [7].
The function of TLR9 is relatively well-characterized
in mammals; however, its function in lower vertebrates
remains obscure. TLR9 has been identified in teleosts
[10-14], and the expression of the protein in Atlantic
salmon (Salmo salar) leukocytes is inducible by IFN-γ
[15]. It has been shown that the bacterial DNA and
CpG ODNs are able to activate immune cells in fish
[16,17]. In particular, research has found that the
upregulation of proinflammatory cytokine in CpG-
stimulated trout macrophages relies on efficient en-
dosomal acidification [18]. Like in mammals, salmon
leukocytes are able to distinguish between diffe-
rent classes of CpG ODNs by upregulating type I IFN
and stimulating lymphocyte proliferation [19] and
data suggests that in Japanese flounder (Paralichthys
olivaceus) TLR9 is involved in the up-regulation of a
tumor necrosis factor-alpha (TNFα) promoter by CpGs
[11]. These data indicate that the TLR9 function is
conserved throughout the vertebrate classes; however,
direct interaction between stimulatory CpG ODN and
TLR9 has not been demonstrated in non-mammalian
vertebrates, so far.
The major goal of the current study has been to
characterize the ability of a salmon TLR9 homolog
(SsTLR9) to interact and mediate the response
to immunostimulatory, phosphorothioate (PS)-modified
CpG ODNs. The results demonstrate that the binding of
SsTLR9 to PS-modified ODNs is not dependent on the
presence of CpGs; however, the affinity of this inter-
action is pH-dependent. Transgenic SsTLR9 is able to
spontaneously activate IFN-stimulated response element
(ISRE)-containing promoter constructs. Nevertheless,
unlike in primary leukocytes, it fails to colocalize with
CpG ODNs when overexpressed in salmonid cell lines.
The study further identifies proteins that contain RNA
recognition motifs (RRM), including heterogeneous
nuclear ribonucleoprotein A0 (hnRNPA0) and nuclear
receptor coactivator 5 (NCOA5), as potential media-
tors of the effects of exogenous DNA in salmon im-
mune cells.Results
SsTLR9 binds phosphorothioate-modified ODNs through
a CpG-independent but a pH-dependent mechanism
A pull-down approach was used in order to find out
whether SsTLR9 is able to bind CpG ODNs. Adher-
ent mononuclear phagocytes isolated from head kid-
ney were first stimulated for 48 hours with IFN-γ
[20] in order to upregulate the SsTLR9 protein [15]
and then stimulated for 2 hours with biotiny-
lated CpG-B prior to lysis and coprecipitation with
streptavidin-conjugated magnetic beads. The Western
blot (WB) results shown in Figure 1A demons-
trate that SsTLR9 coprecipitates with the streptavidin
beads only when the cells have been treated with
biotinylated but not with non-labelled CpG-B ODNs.
Furthermore, addition of a 5-fold higher dose of
non-labelled CpG-B (10 μM) to the biotinylated
CpGs prior to stimulation significantly reduced the
amount of the coprecipitated SsTLR9, which further
confirmed the specificity of the binding. TLR9 is
known to interact with DNA in acidified organelles
including endosomes and lysosomes [8]. To analyse
the efficiency of the binding of CpG ODNs to
SsTLR9 under different pH conditions, the acidity of
the lysis buffer was adjusted using HCl. The results
presented in Figure 1B show that the efficiency of
coprecipitation of both CpG-B and non-stimulatory,
inverted CpG-B ODNs with TLR9 increases gradually
with the reduction of the pH from 7.5 to 5.5. There-
fore, the binding of SsTLR9 to ODNs is independent
of their immunostimulatory capacity and is most effi-
cient under low pH.
SsTLR9 up-regulated by CpG-B and IFN-γ translocates to
endosomal compartments where it colocalizes with its
ligand
In order to interact with its ligand and to initiate sig-
nalling, TLR9 needs to be translocated from endoplas-
mic reticulum to the endosomes [8]. In the current
study, immunostaining combined with confocal micros-
copy analysis confirms that both in CpG and IFN-
γ-treated mononuclear phagocytes, SsTLR9 colocalizes
with fluorescent CpG-B in granules and vesicles
(Figure 2A). While SsTLR9 staining in resting pha-
gocytes is not clearly distinguishable from the back-
ground, stimulation with CpG-B for 24 hours results
in detectable signal, most of which is found in
cytoplasmic granules and speckles where it colocalizes
with the endocytosed CpGs. The results presented in
Figure 2B indicate that in primary mononuclear
phagocytes, the endocytosed CpGs accumulate in tubu-
lar structures and vesicles. Most of the vesicles are
LysoSensor-positive indicating that these are maturing
endolysosomes. Priming the cells with IFN-γ results in
Figure 2 CpG ODNs colocalize with endogenous SsTLR9 in
primary salmon mononuclear phagocytes. A, The head kidney-
derived cells were incubated on coverslips and following the
indicated treatments the cells were processed for immunostaining
and confocal microscopy as described in “Methods”. Treatment
with fluorescent CpG-Cy5 (green pseudocolor) for 24 hours
modestly up-regulated SsTLR9 which was detected in small
granules. Pretreatment with IFN-γ for 48 hours enhances the
SsTLR9 expression which upon addition of CpG-B is transported to
vesicles that also contain CpG ODNs. Colocalization visible as
yellow coloring in the merged images is indicated with arrows in
the magnifications. The nuclei were stained with SYTOX Green
(blue pseudocolor). NS stands for “no stimulation”. B, In live cells, CpG-B
accumulates in tubular structures (arrowhead) and acidified vesicles
(arrow) which, most likely, represent maturing endosomes. The cells
were stimulated as described for panel A. Endolysosomes were stained
with LysoSensor Green (pKa 5.2) and the cells were observed alive.
Figure 1 SsTLR9 binds PS-modified ODNs through a CpG-
independent but a pH-dependent mechanism. A, Specific
binding of CpG-B ODNs to SsTLR9. To up-regulate the SsTLR9
protein, primary salmon mononuclear phagocytes were pretreated
with IFN-γ for 48 hours, as indicated. The cells were further
stimulated with either biotinylated “+” or non-biotinylated “-” CpG-B
(2 μM) for 2 hours. To further confirm the specificity of the binding,
a sample was treated with biotinylated CpG-B in the presence of
10 μM non-biotinylated CpG-B (indicated with “+/–”). Following the
stimulations, cell lysates were subjected to a pull-down analysis with
streptavidin-conjugated magnetic beads and then analyzed on WB
with SsTLR9 ab. In addition, the whole lysates were analyzed in
parallel to confirm the SsTLR9 up-regulation and loading. In the
pull-down blot, the SsTLR9 signal (~120 kDa) is detectable only in
the samples stimulated with biotinylated CpG ODNs. The addition
of an excess (5-fold higher concentration) of non-biotinylated
ODNs significantly reduces the amount of the co-precipitated
SsTLR9 which further confirms the specificity of the binding of the
receptor to the ODNs. B, The interaction between ODNs and
SsTLR9 is enhanced under low pH conditions. The pull-down was
performed under the conditions described above and the pH of
the lysis buffer was adjusted to the indicated values using 3 M HCl. In
addition, inverted non-stimulatory CpG-B (ODN 2007 T) was included
in the experiment. The results demonstrate that SsTLR9 binds to both
the CpG and the inverted CpG ODNs with similar avidity which was
highest at pH 5.5. The results shown in both panels were confirmed
in at least two independent experiments.
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which correlates with the enhanced SsTLR9 expression
and colocalization with CpGs, as compared to non-
primed cells (Figure 2A). LysoSensor staining is not
compatible with immunocytochemistry since it is des-
troyed by membrane permeabilization. However, the
fact that most of the CpG positive vesicles in IFN-γ
primed cells are LysoSensor-positive and that a consid-
erable number of them, are SsTLR9-positive indicates
that it is very likely that at least some of the SsTLR9-
CpG interaction occurs in endolysosomes.SsTLR9, overexpressed in Chinook salmon embryo (CHSE)
cells, spontaneously upregulates the transcriptional
activity of ISRE-containing promoters but the receptor
fails to respond to CpG-stimulation
Reporter gene assays (RGAs) are commonly used to
assess the function of genes through a “gain of func-
tion” approach. Namely, overexpression of immune
molecules such as TLR homologs and their down-
stream signalling mediators in cells lines that don’t
express these proteins may result in an enhanced re-
sponse to the ligands that require their presence. In
the current study, CHSE cells were used for the
RGAs as these cells are transfectable (up to 20-30%;
Iliev, unpublished observations) with transfection
reagents with low toxicity such as FuGene (Roche).
As shown in Figure 3A, after transfection with a
Figure 3 Transgenic SsTLR9, overexpressed in CHSE cells, spontaneously upregulates ISRE-containing promoters but it does not affect
the response to CpGs. A, The cells were cotransfected with the indicated firefly luciferase reporter constructs and either a SsTLR9-expressing
plasmid or the empty vector (EV), as indicated. After incubation for 48 hours, to allow for accumulation of transgenic protein, the cells were
stimulated for 24 hours with CpG-A, CpG-B and poly(IC). The inducible expression of the firefly luciferase was normalized using the control Renilla
luciferase values and is presented as relative luciferase units (RLU). Overexpression of SsTLR9 upregulated the activity of all of the tested
promoters except the NFkB reporter. The stimulation of control cells with CpGs and poly(IC) also activated these promoters with variable
intensity. The combination of SsTLR9 overexpression and stimulation gave no enhanced response. The error bars show the standard deviation,
N = 5, *P < 0.05 vs. EV controls. B, CHSE cells do not express detectable endogenous TLR9 protein. The lysates used for the RGAs were analysed
on WB with the SsTLR9 ab. As the antigenic peptide used for the generation of the ab is conserved across Salmo and Oncorhynchus taxa, the ab
is expected to recognize the Chinook salmon homolog with similar affinity.
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the Cytomegalovirus (CMV) promoter, the activity of
the salmon IFNa1 promoter, the trout Mx1 promoter
and a promoter containing tandem ISRE repeats were
significantly upregulated. In all of these promoters
ISRE elements are essential for their activity [21,22].
In contrast, the activity of the NFkB promoter con-
struct did not seem to be affected under these ex-
perimental conditions. When control (EV-transfected)
cells were stimulated with CpG-A, CpG-B and poly
(IC), the ISRE and the Mx promoters were modestly
activated. The upregulation was most pronounced
with the Mx promoter and upon poly(IC) stimula-
tion. No synergistic promoter upregulation could be
observed when TLR9-transfected cells were incubated
with any of the stimulants.Aliquots from the RGA samples were analysed by
Western blotting to check the expression of the
transgenic SsTLR9 and to investigate whether en-
dogenous TLR9 is expressed in CHSE cells. Results
shown in Figure 3 demonstrate that, while the ex-
pression of the transgenic SsTLR9 is abundant, no
sign of endogenous SsTLR9 can be detected in the
stimulated samples, even after the WB membrane
has been developed with an ultra-sensitive substrate
(as described in the “Methods” section). The TLR9
mRNA expression in CHSE cells was analysed with a
Taqman assay. The analysis did not detect TLR9
mRNA in non-treated CHSE cells while only weak
expression was detected after the cells had been
stimulated with IFNa1 for at least 48 h (results not
shown).
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lysosomes but fail to translocate ectopically expressed
SsTLR9 into these compartments. Also, in the salmon
head kidney-derived cell line TO, no colocalization
between the CpGs and SsTLR9 was found
To test whether CHSE cells can efficiently accumulate
CpG ODNs in endolysosomal compartments, the cells
were stimulated for different periods with fluorescent
CpGs. The late endosomes and lysosomes (pH < 5.5)
were stained with LysoSensor Green and the colo-
calization was analysed with confocal microscopy.
Within 15 min of stimulation, CpG ODNs could be
detected in small vesicles; however, at this time point,
there was no clear colocalization with LysoSensor-
positive vesicles (Figure 4A). After 60 min, some of the
endocytosed CpGs entered the acidic vesicles indicating
transition from early to late endosomes. At 24 hours
post-stimulation, significant amounts of CpG-B ODNs
were accumulated in late endosomes and lysosomes. In
addition, the fluorescent CpGs could be observed in
tubular structures which most likely represent the tubu-
lar lysosomal system. These data indicate that CHSE
cells have the capacity to accumulate large amounts of
CpG and to redistribute them from early endosomes to
acidified vesicles and tubular compartments of the
endo-lysosomal system.Figure 4 CHSE cells accumulate significant amounts of CpGs in endol
compartments; similarly, TO cells, a salmon head kidney-derived cell
compartments. A, Live CHSE cells at different time points after addition o
LysoSensor Green (LSG). Endocytosis of the CpG ODNs is visible within 15 m
stained endolysosomes. Colocalization with LysoSensor Green is detectable
early to late endosomes and lysosomes. Within 24 hours, significant amoun
structures, the later of which most likely represent tubular endosomes/lyso
(Figure 2), SsTLR9 overexpressed in CHSE cells does not colocalize with CpG
staining, the plasmid expressing TLR9 was mixed with a plasmid expressing
observed in salmon TO cells, a poorly-transfectable cell line derived from sa
indicated with dashed boxes.To determine the intracellular distribution of ectopically
expressed SsTLR9, CHSE cells were cotransfected with an
SsTLR9-expressing plasmid and a vector expressing
enhanced green fluorescent protein (EGFP). The EGFP ex-
pression was used as a positive control to identify
transfected cells. When the transfected CHSE cells were
stained with the SsTLR9 antibody, specific signal was
observed only in cells that express the cotransfected
EGFP confirming the specificity of the immunostaining
(Figure 4B). Although these cells had accumulated signifi-
cant levels of CpG ODNs 24 hours after stimulation, unlike
in primary mononuclear phagocytes, no colocalization be-
tween transgenic SsTLR9 and Cy5-labelled CpG ODNs
could be observed. Similar results were obtained when TO
cells, a cell line derived from salmon head kidney was used
(Figure 4C).
Isolation of CpG-B ODN-binding proteins from primary
salmon mononuclear phagocytes. Cytoplasmic EGFP-
hnRNPA0 fusion protein colocalizes with CpG-B ODNs
The pull-down experiments in the current study demon-
strate that SsTLR9 expressed in primary head kidney
mononuclear phagocytes specifically coprecipitates with
CpG ODNs. To identify other molecules that might be
involved in the CpG recognition and signalling, proteins
that coprecipitated with biotinylated CpGs were analysedysosomes but fail to relocate transgenic SsTLR9 into these
line do not translocate CpGs into the CpG-containing
f Cy5-CpGs (red). Late endosomes and lysosomes are stained with
in in small vesicles without clear colocalization with the LysoSensor-
within 60 min indicating transition of the endocytosed CpGs from
ts of CpGs are detected both in acidic vesicles and in tubular
somes. B. Unlike the endogenous SsTLR9 detected in primary cells
s. To label transfected cells as an indicator of the specificity of the
EGFP (green). Cy5-CpGs are shown in blue pseudocolor. C, same is
lmon head kidney. BF stands for bright field. The magnified areas are
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tially, the cell isolation, stimulation and isolation was
performed as in the experiments used for the chara-
cterization of SsTLR9 binding. As a result, in addition to
the many non-specific bands visible on the silver-stained
SDS-PAGE gels, three distinct bands that appeared to
specifically bind and copurify with the CpG-B ODNs
were detected (Figure 5). These bands appeared only in
lanes loaded with samples from cells treated with
biotinylated ODNs. The intensity of their staining
correlated with the concentration of the ODNs and most
importantly, stimulation of the cells in the presence of
an excess of unlabelled CpG-B ODNs inhibited their
purification. These bands were isolated and subjected to
matrix-assisted laser desorption/ionization-time-of-flight
(MALDI-TOF) analysis, however, due to the extremely
low protein amount, most of which is destroyed by the
silver-staining, no proteins could be identified. There-
fore, an alternative approach was undertaken in order to
circumvent the need to isolate protein bands through
SDS-PAGE/silver staining. To reduce the background,
instead of boiling in the presence of LDS sample buffer,
the proteins were released from the magnetic beads
through incubation with either a combination of un-
labelled CpG ODNs and biotin, or CpG ODNs only. The
silver stained gels shown in Figure 5B demonstrate that,
through this approach, the contamination of the sam-
ples with proteins that non-specifically attach to the
streptavidin-conjugated magnetic beads has been signifi-
cantly reduced. Using a combination of unlabelled
ODNs and biotin seemed to be a more efficient recoveryFigure 5 Isolation of CpG-B ODN-binding proteins from primary salm
polyacrylamide gel showing ODN-specific, dose-dependent co-precipitation
with the indicated concentrations of biotin-labeled and/or non-biotinylated
samples were further boiled in LDS sample buffer and subjected to PAGE a
the co-precipitation of the bands indicated with “*” suggesting that these
identify the CpG-binding proteins through MS, milder elution techniques w
CpGs only (right) as described in “Methods”.method for proteins that bind CpG-ODNs; however,
there were still non-specific bands which most likely in-
clude biotin-binding proteins. Incubation of the beads
with the unlabelled ODNs resulted in a very low protein
recovery; however, due to the superior purity of the sam-
ple, an aliquot of it was used directly for tryptic diges-
tion and LC MS-MS analysis as described in “Methods”.
The proteins identified in this sample are listed in
Table 1.
Of these, NCOA5 and hnRNPA0 contain RRMs
domains which are known for their binding affinity for
RNA and DNA and may, potentially, be involved in dir-
ect binding to the CpG-B ODNs in the current study. A
third identified protein, actin-beta (ACTB), is a major
component in the cell cytoskeleton. It is involved in
multiple cellular functions and is known to interact with
multiple targets. Therefore, its copurification with
CpG-B ODNs may be mediated through other proteins
that directly bind to the ODNs. Interestingly, hnRNP A0
protein has previously been shown to associate with
CpG ODNs in pull-down experiments using a mamma-
lian microglial cell line [23]. In the current study, using
an antibody recognizing hnRNPA0 the interaction with
the ODNs was confirmed. As seen in Figure 6A,
hnRNPA0 specifically coprecipitates with CpG-B-ODNs.
It is well known that, like other members of its
populous family, hnRNPA0 is located predominantly in
the cell nucleus; however, as RNA-binding proteins
some hnRNPs are shuttled between the nucleus and the
cytoplasm and in the latter they may associate with RNA
granules [24]. As shown in Figure 6B, overexpression ofon mononuclear phagocytes. A, Image of a silver-stained
of putative CpG-B ODN-binding proteins. The cells were incubated
CpG-B ODNs prior to co-precipitation as described in Figure 1A. The
nd silver staining. Addition of an excess of unlabelled CpG-B inhibits
represent proteins that specifically bind to the ODNs. B, In order to
ere used either through a combination of biotin and CpGs (left) and
Table 1 CpG ODN-binding proteins identified through LC-MS/MS
Protein ID Pred. MW (kDa) Identified peptide sequence Score Expect
NCOA5; Nuclear receptor coactivator 5 (ACI33352.1) 64.84 DLGMVVDLIFLNTEVSLTQALEDVGR 128 1.7e-012
TPFAIIITQQHQVHR 54 6.8e-005
RYDTDRPVDCSVIVVNK 3 19
hnRNPA0; Heterogeneous nuclear ribonucleoprotein A0 (ACI32918.1) 31.5 LFVGGLNVDTDDDGLRK 60 4.3e-005
REDAGKPEALAKV 10 11
ACTB; Actin, cytoplasmic 1 (ACI67042.1) 41.76 RVAPEEHPVLLTEAPLNPKA 35 0.0031
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mic localization of the transgenic protein. Whereas most
of the GFP-labelled fusion protein has nucleic distribu-
tion, in doublets, which appear to be in the process of, or
have recently finished cytokinesis, hnRNPA0 is also seen
in the cytoplasm. In some cells, cytoplasmic granules of
the fusion protein also colocalize with endocytosedFigure 6 Salmon hnRNPA0 binds CpG-B ODNs and colocalizes
with CpG-B ODNs. A, Western blot with mouse anti-hnRNPA0
antibody confirms that the salmon homolog expressed in
mononuclear phagocytes interacts with CpG-B ODNs. The
experiment was performed as in Figure 1A. B, Transgenic salmon
hnRNPA0 is detected both in cell nuclei and cytoplasm and it
colocalizes with fluorescent CpG-B. CHSE cells were transfected with
a plasmid expressing an EGFP-hnRNPA0 fusion protein (green) and
stimulated with Cy5-CpG-B as in Figure 2. The transgenic hnRNPA0
was observed mostly in cell nuclei (arrowhead); however, in cells
which appear to be in a process of cytokinesis (boxed area),
hnRNPA0 can be observed in cytoplasmic granules where it
colocalizes with Cy5-CpGB (Arrow). The cell nuclei were counter-
stained with 7-AAD (blue pseudocolor). Note that the emission, but
not the excitation, spectrum of 7-AAD overlaps with that of Cy-5
and therefore, this channel detects both the genomic DNA and the
endocytosed CpGs.CpG-B ODNs thus indicating that the specific inter-
action detected with the pull-down experiments has the
potential to occur in live cells and it is, probably, not
merely an artefact of the experimental procedures.Discussion
The major goal of the current study has been to investi-
gate the potential of SsTLR9 to serve as an immune re-
ceptor for CpG ODNs and to identify additional
proteins involved in the recognition of these molecules
in salmon innate immune cells. The presented results
show that SsTLR9 does have the capacity to participate
in the recognition of CpGs in Atlantic salmon mono-
nuclear phagocytes as specific binding has been
demonstrated. Unlike another study in which ODNs
were added to cell lysates prior to coprecipitation [25],
in the current research, the cells were first stimulated
with the ligand, washed extensively and then lysed and
processed for coprecipitation. This approach results in
relatively poor protein recovery. However, it should be
considered that, eukaryotic cells express large numbers
of proteins with sequence-dependent and independent
binding affinity to different types of nucleic acids. There-
fore, the experimental approach where cell lysates are
mixed with labelled nucleic acids could result in isola-
tion of proteins that in live cells may not be able to
interact with the immunostimulatory ligands due to
spatial sequestration. Furthermore, the ligand-binding
studies for TLRs can be additionally complicated by the
specific conditions needed by some TLRs to assume effi-
cient ligand-binding conformation. This is particularly
important for endosomal TLRs, including TLR9, which
has been shown to require proteolytic cleavage and low
pH in order to be able to bind and activate immune re-
sponse to foreign nucleic acids [26]. In agreement with
this, in the current study adjusting the pH of the lysis
buffer resulted in more efficient SsTLR9 recovery. In this
case, the low pH most likely prevented the dissociation
of the CpG that had already been associated with the re-
ceptor in the endosomes. While it is still possible that
some of the coprecipitated SsTLR9 might have
interacted with the ODN after the lysis, the immu-
nostaining confirmed that SsTLR9 colocalizes with CpG-
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the CpG-positive vesicles were also LysoSensor-positive
indicates that these are maturing endolysosomes (pH <
5.2). These results are in agreement with previous stud-
ies with primary trout macrophages that have shown
that the immunostimulatory capacity of CpGs de-
pends on processes in which endosomal acidification is
required [18].
Studies on mammalian TLR9 have indicated that bind-
ing to ODNs is not sequence-dependent, while the
activation of the receptor relies on CpG-induced con-
formational changes [27]. Furthermore, it has been
demonstrated that in order to assume efficient ligand-
binding conformation, TLR9 needs to be processed by
endosomal proteases [9,28]. This is considered to be a
mechanism through which the cells control the signal-
ling of TLR9 and other nucleic acid-binding TLRs and
prevent their activation by endogenous ligands. In the
current study, no evidence for proteolytic processing of
SsTLR9 could be detected as only the predicted full-
length molecule (~120 kDa) was specifically detected on
the WB. The pull-down study also demonstrated that it
is the full-length SsTLR9, rather than any proteolytically
processed forms, that binds the ODNs. It light of the
studies mentioned above, it might be questioned
whether the SsTLR9 detected in the current study
represents the functional receptor. Although the pro-
cessed form of murine TLR9 had a higher potential to
interact with DNA and signal the presence of CpGs, the
full-length receptor also had some functional capacity.
Furthermore, in another study, the authors showed that
a chimeric TLR9/TLR4 receptor, which translocated to
the cell membrane instead to the endolysosomal
compartments, was still able to recognize DNA although
it had not been proteolytically processed [29]. This study
highlights the importance of the receptor localization for
the control of the immune response to foreign and en-
dogenous DNA molecules. Interestingly, the place of the
proteolytic cleavage which is found between residues
441 and 470 of mouse TLR9 [9] lies within a phylogenet-
ically poorly-conserved region. Sequence alignment of
teleost and mammalian TLR9 sequences has shown that,
in addition to the relatively low amino acid identity, in
teleosts this region harbours a large insertion that is ab-
sent in the mammalian sequences [15]. Therefore it is
possible that the proteolytic processing of TLR9 might
not be present in teleosts. Despite these differences, the
current study has demonstrated that the ODN-binding
capacity of SsTLR9 is pH dependent indicating that the
DNA-binding properties of SsTLR9 in salmon leukocytes
might still be restricted to the endolysosomes,.
The translocation of TLR9 from the endoplasmic
reticulum relies on its association with other molecules
such as the polytopic membrane protein UNC93B1 [30].In the absence of functional UNC93B1, TLR9 cannot be
translocated to the endolysosomal compartments.
Therefore, the difference between the intracellular distri-
bution of endogenously expressed SsTLR9 and its
overexpression in cell lines may be explained by the ab-
sence of the appropriate molecular mechanisms for re-
distribution of SsTLR9 in the cell lines. It is possible that
CHSE and TO cells lack the machinery required for
targeting the receptor to the endosomes. This may also
explain why transgenic SsTLR9 did not augment the
response to CpGs in CHSE cells. Nevertheless, the
SsTLR9 overexpression spontaneously activated the ac-
tivity of promoters that contain ISRE elements. This
indicates that the cloned molecule is functional and
highlights the potential of the receptor to mediate IFN
upregulation and induction of antiviral genes in re-
sponse to pathogens.
As revealed by the current study, the CHSE cells do not
express detectable levels of endogenous TLR9 protein and
they are not able to relocate the transgenic SsTLR9 to
compartments where it may be activated by CpG ODNs.
However, these cells can efficiently endocytose and accu-
mulate ODNs within late endosomes and they do re-
spond to stimulation with different immunostimulatory
nucleotides as demonstrated by the RGAs. This suggests
that CHSE cells use alternative receptors that allow
them to respond to ODNs by activating promoters of
IFN-responsive genes.
As TLR9 is an intracellular receptor that is not
involved in DNA uptake, it is obvious that the uptake
and the distribution of exogenous DNA by cells rely on
other molecules. The endocytosis of CpG ODNs by im-
mune cells has been suggested to be dependent on
receptor-mediated endocytosis, more specifically on the
function of scavenger receptors [31]. However, the exact
mechanisms that regulate the distribution of diffe-
rent types of CpG ODNs within specific endosomal
compartments are still obscure. Studies have also
suggested that, in addition to TLR9, there are other
molecules that mediate the signalling properties of
immunomodulatory DNA sequences [31,32]. The isola-
tion of proteins that specifically bind CpG ODNs and
that could serve as mediators of the biological activity of
CpG ODNs in primary cells, requires development of
techniques for both efficient and specific protein purifi-
cation. The results presented in the current paper sug-
gest that hnRNPA0 and NCOA5 may, potentially, be
involved in the CpG response. Unlike ACTB which
probably copurifies with CpG ODNs through indirect
binding, both hnRNPA0 and NCOA5 possess RRM
domains which have binding affinity for both RNA and
single-stranded DNA suggesting direct interaction with
the ODNs. Of these molecules, hnRNPA0 is particularly
interesting since it has been previously identified as a
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gliobastoma cells [25]. In this study the authors also
identified a number of other ODN binding proteins;
however, the experimental approach chosen by these
researchers (i.e. adding the ODNs to the cell lysates ra-
ther than stimulating viable cells) allows for the isolation
of proteins that in viable cells may not have access to
the endocytosed CpGs.
The hnRNPA0 belongs to a protein family whose
members have predominantly nuclear distribution and,
therefore, it is questionable whether the observed inter-
action may be an artefact issuing from the binding of
the protein to CpG ODNs released by endosomes after
the cell lysis. However, the experiments with transgenic
salmon hnRNPA0 presented here demonstrate that in
dividing CHSE cells this molecule is found mostly in the
cytoplasm. In the current paper, it is also shown that the
hnRNPA0-GFP fusion protein colocalizes with CpG
ODNs in granular structures within the cytoplasm of
CHSE cells indicating that it is likely that the observed
interaction has occurred in the live cells prior to, rather
than after the cell lysis and that this binding might have
biological significance..
The functions of mammalian hnRNPA0 are still poorly
characterized. Since the general functions of the
members of the hnRNP family are, posttranscriptional
RNA processing and transport [33], it is not very likely
that hnRNPA0 may be directly involved in the intracel-
lular signalling events triggered by CpGs. Interestingly, it
has been suggested that, in mouse, this protein might be
implicated in the regulation of the immune response to
LPS stimulation [34]. More specifically, upon LPS stimu-
lation of mouse macrophages, this protein binds to AU-
rich elements (AREs) of Cyclooxygenase-2 (COX-2),
TNF-α and macrophage inflammatory protein-2 mRNAs
suggesting a role in the regulation of their stability and
the cytokine production. Currently, there is no func-
tional data linking the capacity of hnRNPA0 to bind
CpG ODNs with its potential to regulate cytokine stabil-
ity. In this regard; further studies in this direction would
be relevant.
Conclusions
The current study has indicated that SsTLR9 has the
capacity to bind PS-modified oligonucleotides through
a sequence-independent but a pH-dependent mechan-
ism. The potential of this receptor to activate IFN
responses is highlighted by the presented func-
tional studies showing its capacity to activate ISRE-
containing promoters. The data further indicate that
the redistribution of this receptor and its colocalization
with CpG ODNs within endosomal compartments is
cell type-dependent. Finally, the study identifies the
nucleotide-binding proteins hnRNPA0 and NCOA5 asCpG ODN-binding proteins. Further studies are nee-
ded to investigate the sequence specificity of these
interactions and to investigate whether these proteins




Atlantic salmon (Salmo salar) strain Aquagen standard
(Aquagen, Kyrksæterøra, Norway), of 500 g, were
obtained from the Tromsø Aquaculture Research Station
(Tromsø, Norway). The fish were kept at about 10°C in
tanks supplied with running filtered water and were fed
on commercial, dry food (Skretting, Stavanger, Norway).
All experiments were performed according to the
guidelines from the national committee for animal ex-
perimentation (Forsøksdyrutvalget, Norway).
Isolation and stimulation of primary leukocytes from
Atlantic salmon
Head kidney (HK) leukocytes were isolated as described
by Strandskog et al. [19]. The cells were seeded in
60 mm cell culture dishes at a density of 2.1 × 10^7 cells
per dish. After 24 h of incubation, the cells were washed
with fresh L15 medium and incubated for another 24 h
in L15 supplemented with 5% FBS and antibiotics prior
to treatment. To up-regulate SsTLR9 protein, the cells
were treated with 50 U/ml of recombinant rainbow trout
IFN-γ [20] for 48 hours prior to stimulation. The
stimulations (2 hours) were performed with specified
concentrations of CpG-B (2006T: TCGTCGTTTTG
TCGTTTTGTCGTT) or inverted, non-stimulatory
CpG-B ODN (2007T: TGCTGCTTTTGTGCTTTTG
TGCTT) (Eurogentec). All of the phosphodiester links
were substituted with PS bonds. The ODNs were
biotinylated a using PHOTOPROBEW (Long Arm) Biotin
kit (Vector labs) according to the manufacturer’s
instructions. Briefly, 400 μM ODNs dissolved in TE buf-
fer (pH 8) were mixed with an equal volume of
PHOTOPROBEW (LA) Biotin, citrate salt (FW = 838.9)
in a PCR tube. The mixture was subjected to thermal
coupling by heating to 95°C for 30 min. The reactions
were purified to remove unlabelled bioting with Zeba™
Spin Desalting Columns, 7 K MWCO (Pierce). The cells
were stimulated with 2 μM biotinylated or unlabelled
ODNs unless otherwise indicated in the figures.
All experiments were performed according to the
guidelines from the national committee for animal ex-
perimentation (Forsøksdyrutvalget, Norway).
Pull-down procedures
Following the stimulations the cells were washed 3x with
PBS, to remove non-incorporated ODNs, and lysed in
500 μl of lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM
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supplemented with a protease inhibitor mixture (Com-
plete EDTA-free; Roche Applied Science). To analyse
the TLR9 binding efficiency under different pH
conditions, the acidity of the lysis buffer (original
pH 7.5) was adjusted using 3 M HCl. The cell lysates
were cleared by centrifugation for 15 min at 15,000 × g.
and 50 μl of Streptavidin-coupled Magnetic Beads
(DynabeadsW, Dynal) were added to each sample. The
Magnetic Beads were washed in lysis buffer prior to
addition. The samples were rotated for 45 min at 4°C and
washed 5x with lysis buffer using a microcentrifuge tube
magnetic stand. For the Western blot analysis, the proteins
were eluted by heating the beads (70°C for 10 min) in LDS
sample buffer (Life Technologies). The samples used for
mass spectrometry were eluted using milder elution
conditions - the beads were incubated for 20 min in 50 μl
of lysis buffer supplemented with 0.5 μg/ml of biotin and
2 μM ODNs or 2 μM ODNs only.
Western blot (WB)
The protein samples prepared in LDS buffer were
analysed as previously described [35] using NuPAGE
Novex Bis-Tris 4–12% gels (Life Technologies). The
SsTLR9 antibody has been previously characterized [15]
and was used at 1:1000-fold dilution. The anti-mouse
hnRNP antibody [34] was kindly provided by Dr Simon
Rousseau, University of Dundee and was used at 1:500
dilution. The membranes probed with the SsTLR9 anti-
body were developed with the SuperSignal West Femto
ultra-sensitive substrate whereas hnRNPA0 signal was
developed with the less-sensitive SuperSignal West Pico
substrate (Pierce). The membranes were exposed to
Lumi Film Chemiluminescent Detection film (Roche).
Immunocytochemistry and confocal microscopy
Primary mononuclear phagocytes, Chinook salmon
embryo CHSE-214 cells [36] and salmon head kidney-
derived TO cells [37] were incubated on coverslips and
processed as previously described [38]. The SsTLR9 anti-
body was applied using a 1:1000-fold dilution. To visual-
ise endolysosomes in live cells, CHSE cells grown in
Lab-Tek™ Chambered Coverglass slides (Nunc) were
incubated with 1 μM LysoSensor™ Green DND-189 (Life
technologies) for 30 min, washed and subjected directly or
following the indicated stimulations with CpG-B-Cy5
(Eurogenetech) to confocal microscopy. The transfections
of CHSE and TO cells were performed using FuGeneHD
(Roche) as previously described [35], The expression
constructs include pDEST12.2 (Invitrogen), pDESTEGFP
C1 [35] and pDEST12.2-SsTLR9 [39]. SYTOXW Green
and 7-aminoactinomycin D (7-AAD), which were used
to stain cell nuclei, were purchased from Life Technolo-
gies. The images were taken using an Axiovert 200microscope equipped with an LSM510-META confocal
module (Zeiss).
Reporter gene assays (RGA)
The RGAs were performed as previously described [35].
The reporter that contains the promoter region I of the
Atlantic salmon IFNa1 [21] was provided by Prof. Børre
Robertsen (University of Tromsø, Norway). The rainbow
trout Mx1 promoter construct was described earlier [22].
The ISRE reporter was purchased from SABiosciences.
The Poly(I:C) was purchased from Invivogen. PS-
modified CpG-B and CpG-A (ODN 2216TGGGGGAC
GATCGTCGGGGGG) were obtained from Eurogenetech.
The firefly luciferase values were normalized using the
Renilla luciferase levels, and the values were presented as
relative luciferase units (RLU).
Mass spectrometry (MS)
To analyse the efficiency of the pull-down and the purity
of the coprecipitation, the samples were subjected to
SDS-PAGE, as described above, and silver staining using
the SilverQuest™ Silver Staining Kit (Life Technologies).
Samples which had lowest background were further
analysed with MS to identify potential CpG ODN-
binding proteins. The MS analysis was performed at the
Proteomic Unit at University of Bergen (PROBE). The
protocol included: 1. Reduction and alkylation; Pos-
sible -S-S- bridges were reduced with DiThioTreitol
from Amersham Biosciences, #171318-02) followed by
alkylation with iodoacetamide (Sigma Aldrich, I-6125),
to prevent oxidation and formation of new -S-S- bridges.
2. Digestion (peptide fingerprint); Porcine Trypsin
from Promega (#V 511A) was used to digest the
samples (16 hours at 37°C). The protease activity was
stopped by acidification using 1% TFA (Trifluoroacetic
acid). 3. Filtering/desalting of samples; An nC18
StageTip (Stop and go extraction Tip) column
(Rappsilber, Ishihama et al. 2003) was used. The bound
peptides were eluted by passing 10 μl 70% acetonirile/
0.1% formic acid through the column. 4. Nano-LC
was performed with Ultimate 3000 nano-LC (Dionex
Corporation, USA) with a nC18 enrichment column
(C18 Pepmap 100 from Dionex, 5 μm particle size,
100 Å pore size, 300 μm i.d. × 5 mm) and an nC18
analytical column (C18 Pepmap 100 from Dionex;
3 μm particle size, 100 Å pore size, 75 μm× 150 mm).
5. Mass spectrometry; The eluted peptides from the
nano-LC were ionized (ESI, ElectroSpray Ionization) and
analyzed with a QToF Global (Quadrupole Time of Flight
from Waters, USA) using automatic MS to MSMS
switching (DDA, Data Dependent Analysis). 6. MS/MS
search; The mass spectra of fragmented peptides were
smoothed (Savitzky Golay), centered, and combined in
a merge file. This merge file was then used to search
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matrixscience.com/daemon.html) was used to search
the obtained MSMS spectra in a subset of the NCBInr
database consisting of protein sequences from Class
Actinopterygii (ray-finned fishes).
Data analysis
The RGA data was analysed with two-way ANOVA,
followed by Bonferroni post-tests. Statistical analyses
were performed using the GraphPad Prism6 software.
The value of p < 0.05 was considered to be significant.
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